Member access

4-Traders Homepage  >  Shares  >  AUSTRALIAN SECURITIES EXCHANGE LIMITED  >  Avita Medical Ltd    AVH   AU000000AVH4

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 

Avita Medical Ltd : Avita Medical Ltd. CEO William Dolphin, Ph.D. Interviewed by Stock News Now

02/15/2013| 03:52am US/Eastern
Recommend:
0
NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM--(Feb 14, 2013) - William Dolphin, Ph.D., the CEO of regenerative medicine company  Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY), was interviewed by SNNLive last week. Dr. Dolphin provides an update on Avita's flagship product, ReCell® Spray
Recommend :
0
Partner Area
React to this article
 
Latest news on AVITA MEDICAL LTD
31m ago AVITA MEDICAL LTD: Avita Medical Analyst Coverage Initiated by Zacks
04/11 AVITA MEDICAL LTD: Granted japanese patent expands commercial rights for recell..
04/11 AVITA MEDICAL LTD: Granted Japanese Patent Expands Commercial Rights for ReCell..
03/28 AVITA MEDICAL LTD: Avita Medical Skin Regeneration Symposium Attracts Top Europ..
02/15 AVITA MEDICAL LTD: Avita Medical Ltd. CEO William Dolphin, Ph.D. Interviewed by..
02/14 AVITA MEDICAL LTD: Avita Medical Completes ISO Quality Audit, CE Mark Recertifi..
02/07 AVITA MEDICAL LTD: Avita Medical Appoints Dr. Michael S. Perry to Board of Dire..
2012 AVITA MEDICAL LTD: Avita Shareholder Update November 2012
2012 AVITA MEDICAL LTD: Avita Medical Announces Free Issuance Period for Conversion ..
2012 AVITA MEDICAL LTD: Avita Medical Initiates US FDA Study of Its ReCell® Spray-On..
Advertisement
Chart
Duration : Period :
Avita Medical Ltd Technical Analysis Chart | AVH | AU000000AVH4 | 4-Traders
Income Statement Evolution
Avita Medical Ltd : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Stay Connected :
Copyright © 2013 Surperformance. All rights reserved.